Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes.
Anna SchützBirgit M Rami-MerharIngrid Schütz-FuhrmannNicole BlauensteinerPetra BaumannTina PöttlerJulia Katharina MaderPublished in: Journal of diabetes science and technology (2024)
In conclusion, both groups were able to achieve satisfactory glycemic outcomes independent of age, gender, and diabetes duration. However, the PWT1D using OS-AID systems attained an even better glycemic control with no clinical safety concerns.